Ellen Mengshoel Brevik
Overview
Explore the profile of Ellen Mengshoel Brevik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
49
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heyerdahl H, Roe K, Brevik E, Dahle J
Int J Radiat Oncol Biol Phys
. 2013 Jun;
87(1):153-9.
PMID: 23790511
Purpose: The purpose of this study was to investigate the effect of α-particle-emitting (227)Th-trastuzumab radioimmunotherapy on tumor vasculature to increase the knowledge about the mechanisms of action of (227)Th-trastuzumab. Methods...
2.
Abbas N, Heyerdahl H, Bruland O, Brevik E, Dahle J
Curr Radiopharm
. 2013 Apr;
6(2):78-86.
PMID: 23551110
Unlabelled: The aim of the present study was to compare the biodistribution, normal tissue toxicity and therapeutic effect of the alpha-particle emitting 227Th-trastuzumab and the beta-particle emitting 177Lu-trastuzumab in mice...
3.
Heyerdahl H, Abbas N, Brevik E, Mollatt C, Dahle J
PLoS One
. 2012 Aug;
7(8):e42345.
PMID: 22879947
Background: The aim of this study was to investigate therapeutic efficacy and normal tissue toxicity of single dosage and fractionated targeted alpha therapy (TAT) in mice with HER2-expressing breast and...
4.
Abbas N, Bruland O, Brevik E, Dahle J
Nucl Med Commun
. 2012 May;
33(8):838-47.
PMID: 22643311
Objective: The aim of the present study was to compare the biodistribution, normal tissue toxicity, and therapeutic effect of two low-dose rate radioimmunoconjugates (RICs) in mice with HER2-expressing ovarian cancer...